Aim: In the present study, we aimed to compare Dexmedetomidine-Remifentanil and Propofol-Remifentanil combinations in terms of postoperative cognitive functions in hysteroscopy attempts. Material and Methods: A total of 70 ASA I-II patients who were aged between 18 and 65 years were included in the study following the ethics committee approval. The patients were randomized into two groups (n=35), and standard routine monitoring were applied to them. The sedation depth was evaluated with Ramsey Sedation Score (RSS) before and after the sedation; and cognitive functions of the groups were evaluated with the Minimal Mental State Test (MMST). Propofol 1 mg/kg bolus 25-100 µg/kg/min infusion was administered to Group PR, and Dexmedetomidine 1 µg/kg bolus 0.4-0.7 µg/ kg/h infusion dose was administered to Group DR. Remifentanil 0.25 µg/kg bolus 0.04 µg /kg/min infusion was administered to the groups, and the groups were followed to ensure RSS≥4. Result: In cognitive functions, it was observed that there was significant regression in Group PR in postoperative period compared to the preoperative period (p<0.05). The hemodynamic parameters were lower in Group DR than in Group PR at 5th, 10th and 15th minutes following the hysteroscopy (p<0.05). The Modified Aldrete Score in Group DR were high, and pain scores were lower (p<0.05). Satisfaction with the surgeon, patient and anesthetist scores were higher in Group DR. No respiratory depression was observed (p<0.05). Conclusion: We believe that administering Dexmedetomidine-Remifentanil combination in sedation in hysteroscopy ensures better postoperative cognitive function, recovery conditions, analgesia, and patient and surgeon satisfaction compared to the PropofolRemifentanil combination.
INTRODUCTION
Hysteroscopy is the standard diagnostic and treatment modality for the diagnosis and treatment of endometrial pathologies and can be performed with local, regional, general anesthesia, or sedoanalgesia in the lithotomy position (1) .
Local and regional anesthesia applications cause anxiety in patients due to patient positioning and the application area of these anesthetic techniques (2) . If the patients are awake during hysteroscopy interventions, their sudden unexpected leg movements caused by visual and auditory stimuli can impair the surgical vision and sterilization, thereby leading to tissue damage or perforation. Sedoanalgesia, as it leads to relatively better preservation of patient cooperation and physiological reflexes compared to general anesthesia, does not only increase the efficiency of the operation room and patient comfort, satisfaction, and safety but also provides faster recovery (3) . Meaningfully, sedoanalgesia has emerged as an effective anesthetic technique preferred to general anesthesia in daily anesthetic practice (2) .
Although hysteroscopy seems to be a minimally invasive procedure, it involves painful procedures such as cervical dilatation, polypectomy, and myomectomy. Today, hysteroscopy is used in obstetrics and gynecology practice predominantly for the evaluation of infertile women as well as functional and anatomical evaluation of uterine anomalies and for the diagnosis and treatment of abnormal uterine bleeding. Providing adequate anesthesia and analgesia during hysteroscopy is a crucial issue for anesthesiologists. A good anesthetic application can provide well-balanced hemodynamic stability by adequately suppressing the sympathetic response. As a result, since the patient and the physician are both comfortable throughout the sedation period during hysteroscopy, conscious sedation protocols increase the success rate of the procedure. Propofol is frequently used for conscious sedation in hysteroscopy; however, the use of dexmedetomidine, a new sedative agent, has not been sufficiently investigated (4) .
Dexmedetomidine has recently emerged as an alternative to propofol and other sedative agents in conscious sedation applications. Dexmedetomidine is a fat-soluble imidazole derivative and a potent and highly selective α2-adrenoceptor agonist and provides sedation analgesia in which the patients can be awakened and can be cooperated with, without leading to respiratory depression. Moreover, as it does not cause respiratory depression during sedation and analgesia, dexmedetomidine is accepted as an appropriate drug for the interventions performed under local and regional anesthesia (5) .
In this study, we aimed to compare the dexmedetomidineremifentanil and propofol-remifentanil combinations used for conscious sedation during hysteroscopy in terms of postoperative cognitive functions, hemodynamic parameters, sedation, analgesia, recovery, and surgeon and patient satisfaction.
MATERIAL and METHODS
After obtaining an approval from the local ethics committee (Date: November 21, 2017; No: 08), the patients planned for elective hysteroscopy were included in the study. Each patient underwent preoperative evaluation at the Anesthesiology and Reanimation polyclinic at least one day prior to the study. A total of 82 patients planned for hysteroscopy were evaluated. Of these, 12 patients were excluded from the study since they were aged below 18 years or over 65 years, failed to provide a written or oral consent, had serious cardiac, renal, hepatic or respiratory diseases and allergic responses to the agents used in the treatment, or psychomotor dysfunction. As a result, a total of 70 patients aged 18-65 years with an ASA score of I-II were included in the study and were randomized into two groups with 35 patients each. Informed written and oral consents were obtained from each patient or from their parents/guardians. Both the patients and the physicians evaluating the patients were blinded to the study groups. Demographic characteristics of the patients were recorded. Prior to the procedure, the patients were placed on the operation table and standard routine monitoring including Electrocardiography (ECG) monitoring, peripheral oxygen saturation (SpO 2 ), heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean blood pressure (MBP) was performed for each patient in the supine position.
The sedation depth before and after sedation was evaluated with The Ramsey Sedation Score (RSS) and the cognitive functions of the groups were evaluated with the Mini-Mental State Examination (MMSE) (Figure 1 ).
Figure 1. Standardized Mini Mental State Examination
Prior to the surgery, vascular access was established using a 20-gauge cannula inserted into the right or left antecubital vein, followed by intravenous administration of 1000 ml saline solution (0.9% NaCl). Each patient was premedicated with midazolam 0.025 mg kg -1 (Demizolam®, Dem, Turkey).
The patients were randomized by sealed tender and divided into two groups as Propofol-Remifentanil (PR) (n=35) and Dexmedetomidine-Remifentanil (DR) group (n=35). In the PR group, propofol (1% Propofol ® Fresenius Kabi, Turkey) 1 µg/kg was administered, followed by the infusion of 25-100 µg/kg/min. In the DR group, dexmedetomidine (Precedex® Abbott, Istanbul, Turkey) 1 µg/kg/10 min bolus was administered, followed by the infusion of 0.4 to 0.7 µg/kg/h. Subsequently, in both groups, remifentanil (Ultiva ® , GlaxoSmithKline, Belgium) 0.25 µg/kg bolus was administered, followed by the infusion of 0.04 µg/kg/min. Each patient was given O 2 with a nasal cannula at a flow rate of 4-6 L min -1 throughout the procedure. Care was taken to maintain the RSS value at ≥4. When the RSS value was <4, an additional dose of 0.5 mg/kg of propofol or 0.2 µg/kg of dexmedetomidine was administered.
The vital parameters of the patients recorded at the operation table before drug administration were accepted as the baseline values and the subsequent values were recorded every 5 min before and after the administration of loading dose. The recovery score was measured with the Modified Aldrete Scoring (MAS) and the time until MAS 10 was achieved was recorded for each patient (Table  1) . Pain assessment was performed using the WongBaker FACES Pain Rating Scale (WBS) (Figure 2 ). The anesthesiologist, surgeon, and patient satisfaction levels were assessed using a 10-point scale (0: Not satisfied at all, 10: Fully satisfied) (6,7).
Statistical Analysis
In the power analysis, the sample size was determined to be n=31 according to equation n by accepting the primary variable of interest as MMSE and assuming the average score of the test as 20 and the standard deviation as (π) 4, based on an effect size (d) of 1.4, an α score of 0.05, and a power value of 80%. To ensure the reliability of the analysis, 35 patients were included in each group. 
RESULTS
No significant difference was found between the two groups in terms of age, height, body weight, ASA risk classification and the duration of hysteroscopy procedure (p>0.05) ( Table 2) . No change was found between the preand post-operative MMSE scores in the DR group, whereas a significant decrease was observed in postoperative scores in the PR group compared to preoperative scores (p<0.05) ( Table 3 ).
In terms of SpO 2 values, the value at min 5 after induction was significantly higher in the DR group compared to the PR group (p<0.05) (Figure 3 ). In the DR group, the HR, BPD, DBP and MBP values at min 5, 10, and 15 after hysteroscopy were lower than those in the PR group (p<0.05). Figure 3 presents the MBP values. In terms of MBP, the values at min 5, 10, and 15 after hysteroscopy were significantly lower in the DR group compared to the PR group (p<0.05) (Figure 4 ). Table 4 ). In the DR group, the MAS scores were significantly higher and the WBS scores were significantly lower than those in the PR group (p<0.05) ( Table 4 ). The surgeon, patient, and anesthesiologist satisfaction values were found to be significantly higher in the DR group than in the PR group (p<0.05) ( Table 4) . No desaturation and respiratory depression were observed in the DR group and no bradycardia was observed in the PR group. However, bradycardia occurred in 3 patients in the DR group and desaturation occurred in 13 patients and respiratory depression occurred in 8 patients in the PR group.
DISCUSSION
In this study, we found that the administration of dexmedetomidine 1 µg/kg/10 min bolus followed by the infusion of 0.4-0.7 µg/kg/h resulted in lower effects on the cognitive functions and provided a shorter recovery period. We also found that the dexmedetomidineremifentanil (DR) group had more favorable outcomes in terms of surgeon and patient satisfaction compared to the propofol-remifentanil (PR) group.
In our study, as there were no inactive metabolites in propofol and dexmedetomidine at the doses administered and as the drugs caused no re-sedation in any patient, the patients remained conscious enough to communicate, adequate sedation that sustained the surgical comfort of the patients was achieved, and shorter recovery was achieved.
Pain in hysteroscopy is a condition that makes the patients extremely uncomfortable and complicates the access to the uterine cavity (6) . Moreover, this pain has also been reported to cause vasovagal syncope in 0.21-30% of the patients (7). Therefore, pain control is of paramount importance in hysteroscopy as it is a short procedure. In our patients, we used remifentanil in our patients for pain control.
Hysteroscopy is a short endoscopic procedure that can be applied by local, regional, general anesthesia, sedoanalgesia or Monitored Anesthesia Care (MAC) in the lithotomy position. However, when performed with local anesthesia, the patients may feel anxious and may not be able to tolerate it due to patient positioning (8) . For these reasons, we did not prefer local or regional anesthesia in our patients. /h -1 for anesthetic maintenance. In our study, dexmedetomidine 1 µg/kg/10 min bolus was administered in the DR group, followed by an infusion dose of 0.4-0.7 µg/kg/h. The doses administered in our study did not only produce good sedation but also led to no negative effects on the hemodynamic and respiratory parameters and the recovery status of the patients. Kaygusuz et al. (12) compared the use of dexmedetomidine and propofol infusions in patients scheduled for extracorporeal shock wave (ESWL) and also evaluated the requirement for additional fentanyl and noted that the requirement for fentanyl was relatively lower in the dexmedetomidine group. In our study, we found that remifentanil requirement was lower in our patients due to the analgesic effect of dexmedetomidine.
Ramsay et al. (13) used dexmedetomidine to perform conscious sedation in a morbid obese patient with sleep apnea syndrome who was planned for tracheal resection. The authors reported that the patient breathed spontaneously on room air and no desaturation occurred. Scher and Gitlin administered sedation in a patient who had a history of difficult intubation and was scheduled for fiber optic intubation and preferred dexmedetomidine for sedation due to its antisialagogue effect and as it does not cause respiratory depression. The authors reported that good sedation was achieved and the patient tolerated the procedure comfortably, with no need for an extra modification in the oxygen saturation and ventilation and no need for airway manipulation (14) . Similarly, in our study, no desaturation and respiratory depression occurred in the DR group, whereas respiratory depression was significantly higher in the PR group.
In our study, we used a test called Mini-Mental State Examination (MMSE), which was developed by Folstein et al. (15) in 1975. MMSE is a standard test used for evaluating the cognitive functions of the patients such as recalling, attention, and calculation. MMSE is widely used all over the world and is not a definitive diagnostic test but is used by clinicians for screening and monitoring the treatment process to measure the degree of cognitive destruction of the patients. The validity and reliability of MMSE in the Turkish population was performed by Istanbul University Cerrahpaşa Medical School Department of Psychiatry (16).
In our study, a significant difference was observed in the DR group compared to the PR group with regard to early recovery. When the MAS scores of 9 and 10 were achieved, the MMSE was administered in both groups and it was found that the dexmedetomidine group had significantly faster recovery of cognitive functions compared to the propofol group. However, although the recovery of cognitive functions has been mostly evaluated after general anesthesia in the literature, we evaluated it before and after sedation in daily anesthesia.
The neuroprotective effect of dexmedetomidine proven by experimental studies, its action on a single receptor type, and the absence of its anticholinergic adverse effects (17, 18) may have been the reasons for its minimal effect on postoperative cognitive functions.
CONCLUSION
The DR group had higher MAS scores but lower WBS scores compared to the PR group, which can be attributed to the fact that dexmedetomidine reduces pain sensation and increases its analgesic effect in increased plasma concentrations. There is strong evidence suggesting that the stimulation of α-2 receptors produces analgesia at the level of the spinal cord. Dexmedetomidine provides an analgesic effect by binding to the α-2 adrenoreceptors in the spinal cord. We found that the dexmedetomidineremifentanil combination provided more favorable outcomes in terms of the recovery of postoperative cognitive functions, recovery parameters, analgesia, and patient and surgeon satisfaction compared to the propofol-remifentanil combination, although the dexmedetomidine-remifentanil combination caused a decrease in blood pressure at various time periods.
